In summary, our study provides solid evidence supporting the hypothesis that IL6‐AS1 is functionally relevant to inflammation in COPD by promoting IL‐6 expression and outlines a novel mechanism of IL6‐AS1 regulation of COPD progression via EBF1 and IL‐6. This evidence concerns the gene EBF1 and chronic obstructive pulmonary disease.